Mark Hunter
Impact in
- Rheumatology top 2%
- GDF15 and Related Biomarkers
- Obstetrics and Gynecology top 5%
- Endometrial and Cervical Cancer Treatments
Papers in ⓘ
-
- Endometrial and Cervical Cancer Treatments 10
-
- Ovarian cancer diagnosis and treatment 6
- Endometriosis Research and Treatment 5
- Co-authors
- Samuel N. Breit (6 shared papers)David A. Brown (6 shared papers)Asne R. Bauskin (3 shared papers)Bradley J. Monk (5 shared papers)Krishnansu S. Tewari (3 shared papers)Heiko Johnen (2 shared papers)Támara Kuffner (2 shared papers)Xiaohe Luo (1 shared paper)
- Journals
- American Journal of Obstetrics and Gynecology (4 papers)Cancer Research (2 papers)Clinical Cancer Research (2 papers)British Journal of Cancer (1 paper)Investigational New Drugs (1 paper)
- Partner nations
- United StatesAustraliaSouth Korea
In The Last Decade
Mark Hunter
27 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 56
- Rheumatology 520
- Obstetrics and Gynecology 178
- Immunology 348
- Reproductive Medicine 124
- Physiology 356
Countries citing papers authored by Mark Hunter
This map shows the geographic impact of Mark Hunter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Hunter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Hunter more than expected).
Fields of papers citing papers by Mark Hunter
This network shows the impact of papers produced by Mark Hunter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Hunter. The network helps show where Mark Hunter may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Hunter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 211 | |
| 2 | 2006 | 166 | |
| 3 | 2005 | 125 | |
| 4 | 2006 | 99 | |
| 5 | 2007 | 83 | |
| 6 | 2008 | 60 | |
| 7 | 2008 | 48 | |
| 8 | 2015 | 48 | |
| 9 | 2010 | 38 | |
| 10 | 2005 | 30 | |
| 11 | 2009 | 25 | |
| 12 | 2004 | 20 | |
| 13 | A phase II evaluation of cediranib in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study | 2015 | 14 |
| 14 | 2022 | 13 | |
| 15 | 2019 | 12 | |
| 16 | 2003 | 8 | |
| 17 | 2007 | 7 | |
| 18 | 2024 | 6 | |
| 19 | 2024 | 4 | |
| 20 | 2022 | 3 |
About Mark Hunter
Mark Hunter is a scholar working on Obstetrics and Gynecology, Reproductive Medicine, Immunology, Rheumatology and Oncology, having authored 28 papers that have together received 1.0k indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (10 papers), Ovarian cancer diagnosis and treatment (6 papers), GDF15 and Related Biomarkers (6 papers), Endometriosis Research and Treatment (5 papers), Nutrition and Health in Aging (5 papers), Macrophage Migration Inhibitory Factor (5 papers), Cancer Risks and Factors (3 papers) and Reproductive Biology and Fertility (3 papers). The work is most often cited by research in Rheumatology (520 citations), Obstetrics and Gynecology (178 citations), Immunology (348 citations), Reproductive Medicine (124 citations) and Physiology (356 citations). Mark Hunter has collaborated with scholars based in United States, Australia and South Korea. Frequent co-authors include Samuel N. Breit, David A. Brown, Asne R. Bauskin, Bradley J. Monk, Krishnansu S. Tewari, Heiko Johnen, Támara Kuffner, Xiaohe Luo, Jens Koopmann and C. Nicole Rosenzweig. Their work appears in journals such as American Journal of Obstetrics and Gynecology, Cancer Research, Clinical Cancer Research, British Journal of Cancer and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.